Practice Management

Valerie P. Jackson, MD, president of RSNA, suggested that radiologists look within themselves, step out of the reading room and connect with others to move toward this “long desired goal."

Gadolinium-based contrast agents were found in multiple areas of the brain's cerebral cortex, central to cognition, regulating behavior and consciousness, according to research published in Radiology.

An investigation found there was no malicious intent involved and no punishment was handed down, the Wall Street Journal reported. 

The Medscape report surveyed more than 4,300 U.S. physicians across 29 specialities.

While the researchers did find a “modest decline” in 2016, the overall figures are still too high, they explained Nov. 20 in the American Journal of Roentgenology.

The first round of the Champions of Imaging 3.0 competition goes through Feb. 28 of next year and focuses on clinical decision support and appropriate use criteria.

Medical schools are increasingly offering their residents the chance to participate in international experiences and collaborate on research with multiple institutions, particularly in resource-strapped countries. 

Radiologists, medical students and surgeons all agree that AI should be incorporated into diagnostic radiology, but for the most part their perceptions of the technology are drastically different.

No medical specialty outside of radiology and cardiology educate their trainees in image interpretation enough to justify nonradiologist physicians reading studies in the clinical setting, according to new research published in the American Journal of Roentgenology.

Radiologists should expect to see more dementia cases in the near future, but in order to properly care for these patients they must take steps to better understand the condition.

A group of five researchers looked at the relationship between studies read by radiology trainees during their residency and first-time performance on the ABR Core Examination, sharing their findings in Academic Radiology.

“Because BI-RADS 3 breast lesions have up to 2% likelihood of malignancy, it is imperative that optimal follow-up of BI-RADS 3 test results be addressed...," authors of the new study published in JACR wrote.